Myocardial blood flow, function, and metabolism in repetitive stunning

Journal of Nuclear Medicine

Volumn 41, Issue 7, 2000, Pages 1227-1234

  Di Carli, Marcelo F ^a,b   Prcevski, Petar ^a   Singh, Tajinder P ^a   Janisse, James ^a   Ager, Joel ^a   Muzik, Otto ^a   Vander Heide, Richard ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Blood flow; Ischemia; PET; Reperfusion; Stunning

Indexed keywords

ACETIC ACID C 11; AMMONIA; FLUORODEOXYGLUCOSE; GLUCOSE; NITROGEN 13;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLUCOSE UTILIZATION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE WALL MOTION; MYOCARDIAL HIBERNATION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STUNNED HEART MUSCLE;

ANIMALS; CARBON RADIOISOTOPES; CORONARY CIRCULATION; DOGS; ECHOCARDIOGRAPHY; FLUORODEOXYGLUCOSE F18; GLUCOSE; HEART; HEMODYNAMIC PROCESSES; MICROSPHERES; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION; MYOCARDIAL STUNNING; MYOCARDIUM; OXYGEN CONSUMPTION; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033927856     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Rahimtoola SH. The hibernating myocardium. Am Heart J. 1989;117:211-221.
2. Vanoverschelde JL, Wijns W, Depre C, et al. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium. Circulation. 1993;87:1513-1523.
3. Marinho NV, Keogh BE, Costa DC, Lammerstma AA, EU PJ, Camici PG. Pathophysiology of chronic left ventricular dysfunction: new insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation. 1996;93:737-744.
4. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-888.
5. Liedtke AJ, Renstrom B, Nellis SH, Hall JL, Stanley WC. Mechanical and metabolic functions in pig hearts after 4 days of chronic coronary stenosis. J Am Coll Cardiol. 1995;26:815-825.
6. Hacker TA, Renstrom B, Nellis SH, Liedtke AJ. Effect of repetitive stunning on myocardial metabolism in pig hearts. Am J Physiol. 1997;273:H1395-H1402.
7. Institute of Laboratory Animal Resources Commission of Life Sciences, National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press; 1996.
8. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136.
9. Nuutila P, Koivisto VA, Knuuti J, et al. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest. 1992;89:1767-1774.
10. Hutchins GD, Caraher JM, Raylman RR. A region of interest strategy for minimizing resolution distortions in quantitative myocardial PET studies. J Nucl Med. 1992;33:1243-1250.
11. Muzik O, Beanlands RS, Hutchins GD, Mangner TJ, Nguyen N, Schwaiger M. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med. 1993;34:83-91.
12. Armbrecht JJ, Buxton DB, Schelbert HR. Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. Circulation. 1990;81:1594-1605.
13. Gambhir SS, Schwaiger M, Huang SC, et al. Simple noninvasive quanfication method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med. 1989;30:359-366.
14. Gambhir SS. Quantification of the Physical Factors Affecting the Tracer Kinetic Modelling of Cardiac Positron Emission Tomography Data [dissertation]. Los Angeles, CA: University of California; 1990.
15. Geisser S, Greenhouse SW. An extension of Box's results on the use of the F distribution in multivariate analysis. Ann Math Statistics. 1958;29:885-891.
16. Gropler RJ, Siegel BA, Sampathkumaran K, et al. Dependence of recovery of contractile function on maintenance of oxidative metabolism after myocardial infarction. J Am Coll Cardiol. 1992;19:989-997.
17. Fusler V, Badimon L, Cohen M, Ambrose JA, Badimon JJ, Chesebro J. Insights into the pathogenesis of acute ischemic syndromes. Circulation. 1988;77:1213-1220.
18. Hackett D, Davies G, Chierchia S, Maseri A. Intermittent coronary occlusion in acute myocardial infarction: value of combined thrombolytic and vasodilator therapy. N Engl J Med. 1987;317:1055-1059.
19. Bogaty P, Hackett D, Davies G, Maseri A. Vasoreactivity of the culprit lesion in unstable angina. Circulation. 1994;90:5-11.
20. Buxton DB, Schelbert HR. Measurement of regional glucose metabolic rates in reperfused myocardium. Am J Physiol. 1991;261:H2058-H2068.
21. Schwaiger M, Schelbert HR, Ellison D, et al. Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. J Am Coll cardiac. 1985;6:336-347.
22. McFalls EO, Baldwin D, Marx D, Fashingbauer P, Ward H. Temporal changes in function and regional glucose uptake within stunned porcine myocardium. J Nucl Med. 1996;37:2006-2010.
23. Renstrom B, Nellis SH, Liedtke AJ. Metabolic oxidation of glucose during early myocardial reperfusion. Circ Res. 1989;65:1094-1101.
24. Buxton DB, Nienaber CA, Luxen A, et al. Noninvasive quantitation of regional myocardial oxygen consumption in vivo with [1-11C]acetate and dynamic-positron emission tomography. Circulation. 1989;79:134-142.
25. Myears DW, Sobel BE, Bergmann SR. Substrate use in ischemic and reperfused canine myocardium: quantitative considerations. Am J Physiol. 1987;253:H107-H114.
26. Liedlke AJ, DeMaison L, Eggleston AM, Cohen LM, Nellis SH. Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium. Circ Res. 1988;62:535-542.
27. Liedtke AJ, Renstrom B, Hacker TA, Nellis SH. Effects of moderate repetitive ischemia on myocardial substrate utilization. Am J Physiol. 1995;269:H246-H253.
28. Kobayashi K, Neely JR. Effects of ischemia and reperfusion on pyruvate dehydrogenase activity in isolated rat hearts. J Mol Cell Cardiol. 1983;15:359-367.
29. Dodds K, Lamb P, Pentecost B, Nattrass M. Erythrocyle insulin receptors following myocardial infarction in non-diabetic subjects. Ann Clin Biochem. 1986;23:657-660.
30. Harada K, Maekawa T, Abu Shama KM, Yamashima T, Yoshida K. Translocation and down-regulation of protein kinase C-alpha, -beta, and -gamma isoforms during ischemia-reperfusion in rat brain. J Neumchem. 1999;72:2556-2564.
31. Shepherd PR, Kahn BB. Glucose transporters and insulin action: implications for insulin resistance and diabetes mellitus. N Engl J Med. 1999;341:248-257.
32. Buxton DB, Mody FV, Krivokapich J, Phelps ME, Schelbert HR. Quantitative assessment of prolonged metabolic abnormalities in reperfused canine myocardium. Circulation. 1992;85:1842-1856.
33. Weinheimer CJ, Brown MA, Nohara R, Perez JE, Bergmann SR. Functional recovery after reperfusion is predicated on recovery of myocardial oxidative metabolism. Am Heart J. 1993;125:939-949.